{
  "DOI": "10.1007/s10689-006-9112-x",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-006-9112-x",
  "alternative-id": [
    "9112"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Pal",
      "given": "Tuya",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Permuth-Wey",
      "given": "Jenny",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kapoor",
      "given": "Rachna",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Cantor",
      "given": "Alan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sutphen",
      "given": "Rebecca",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2006,
        12,
        7
      ]
    ],
    "date-time": "2006-12-07T04:56:12Z",
    "timestamp": 1165467372000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T17:45:55Z",
    "timestamp": 1559238355000
  },
  "indexed": {
    "date-parts": [
      [
        2023,
        11,
        20
      ]
    ],
    "date-time": "2023-11-20T22:22:10Z",
    "timestamp": 1700518930644
  },
  "is-referenced-by-count": 46,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2006,
        12,
        8
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2007,
          2,
          13
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2006,
            12,
            8
          ]
        ],
        "date-time": "2006-12-08T00:00:00Z",
        "timestamp": 1165536000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-006-9112-x.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-006-9112-x/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-006-9112-x",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "113-119",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2006,
        12,
        8
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2006,
        12,
        8
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2007,
        2,
        13
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1006/gyno.1994.1334",
      "author": "AS Whittemore",
      "doi-asserted-by": "crossref",
      "first-page": "S15",
      "journal-title": "Gynecol Oncol",
      "key": "9112_CR1",
      "unstructured": "Whittemore AS (1994) Characteristics relating to ovarian cancer risk: implications for prevention and detection. Gynecol Oncol 55:S15–S19",
      "volume": "55",
      "year": "1994"
    },
    {
      "DOI": "10.1086/318787",
      "author": "HA Risch",
      "doi-asserted-by": "crossref",
      "first-page": "700",
      "journal-title": "Am J Hum Genet",
      "key": "9112_CR2",
      "unstructured": "Risch HA, McLaughlin JR, Cole DE et al (2001) Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700–710",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1002/cncr.21536",
      "author": "T Pal",
      "doi-asserted-by": "crossref",
      "first-page": "2807",
      "journal-title": "Cancer",
      "key": "9112_CR3",
      "unstructured": "Pal T, Permuth-Wey J, Betts JA et al (2005) BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer 104:2807–2816",
      "volume": "104",
      "year": "2005"
    },
    {
      "author": "S Narod",
      "first-page": "957",
      "journal-title": "Am J Hum Genet",
      "key": "9112_CR4",
      "unstructured": "Narod S, Ford D, Devilee P et al (1995) Genetic heterogeneity of breast–ovarian cancer revisited. Breast Cancer Linkage Consortium. Am J Hum Genet 57:957–958",
      "volume": "57",
      "year": "1995"
    },
    {
      "DOI": "10.1200/JCO.1998.16.7.2417",
      "author": "TS Frank",
      "doi-asserted-by": "crossref",
      "first-page": "2417",
      "journal-title": "J Clin Oncol",
      "key": "9112_CR5",
      "unstructured": "Frank TS, Manley SA, Olopade OI et al (1998) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16:2417–2425",
      "volume": "16",
      "year": "1998"
    },
    {
      "DOI": "10.1016/S0140-6736(94)91578-4",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "692",
      "journal-title": "Lancet",
      "key": "9112_CR6",
      "unstructured": "Ford D, Easton DF, Bishop D (1994) Tea: risks of cancer in BRCA1 mutation carriers. Lancet 343:692–695",
      "volume": "343",
      "year": "1994"
    },
    {
      "DOI": "10.1056/NEJM199705153362001",
      "author": "JP Struewing",
      "doi-asserted-by": "crossref",
      "first-page": "1401",
      "journal-title": "N Engl J Med",
      "key": "9112_CR7",
      "unstructured": "Struewing JP, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401–1408",
      "volume": "336",
      "year": "1997"
    },
    {
      "author": "A Berchuck",
      "first-page": "2433",
      "journal-title": "Clin Cancer Res",
      "key": "9112_CR8",
      "unstructured": "Berchuck A, Heron KA, Carney ME et al (1998) Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res 4:2433–2437",
      "volume": "4",
      "year": "1998"
    },
    {
      "DOI": "10.1038/sj.bjc.6602199",
      "author": "T Bjorge",
      "doi-asserted-by": "crossref",
      "first-page": "1829",
      "journal-title": "Br J Cancer",
      "key": "9112_CR9",
      "unstructured": "Bjorge T, Lie AK, Hovig E et al (2004) BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study. Br J Cancer 91:1829–1834",
      "volume": "91",
      "year": "2004"
    },
    {
      "DOI": "10.1002/1098-1004(200007)16:1\u003c88::AID-HUMU16\u003e3.0.CO;2-G",
      "author": "US Khoo",
      "doi-asserted-by": "crossref",
      "first-page": "88",
      "journal-title": "Hum Mutat",
      "key": "9112_CR10",
      "unstructured": "Khoo US, Ngan HY, Cheung AN et al (2000) Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Hum Mutat 16:88–89",
      "volume": "16",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.ejca.2003.09.016",
      "author": "S Malander",
      "doi-asserted-by": "crossref",
      "first-page": "422",
      "journal-title": "Eur J Cancer",
      "key": "9112_CR11",
      "unstructured": "Malander S, Ridderheim M, Masback A et al (2004) One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden. Eur J Cancer 40:422–428",
      "volume": "40",
      "year": "2004"
    },
    {
      "DOI": "10.1093/hmg/4.10.1953",
      "author": "M Matsushima",
      "doi-asserted-by": "crossref",
      "first-page": "1953",
      "journal-title": "Hum Mol Genet",
      "key": "9112_CR12",
      "unstructured": "Matsushima M, Kobayashi K, Emi M et al (1995) Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients: four germline mutations, but no evidence of somatic mutation. Hum Mol Genet 4:1953–1956",
      "volume": "4",
      "year": "1995"
    },
    {
      "DOI": "10.1002/ijc.11338",
      "author": "J Menkiszak",
      "doi-asserted-by": "crossref",
      "first-page": "942",
      "journal-title": "Int J Cancer",
      "key": "9112_CR13",
      "unstructured": "Menkiszak J, Gronwald J, Gorski B et al (2003) Hereditary ovarian cancer in Poland. Int J Cancer 106:942–945",
      "volume": "106",
      "year": "2003"
    },
    {
      "DOI": "10.1056/NEJM200107263450401",
      "author": "B Modan",
      "doi-asserted-by": "crossref",
      "first-page": "235",
      "journal-title": "N Engl J Med",
      "key": "9112_CR14",
      "unstructured": "Modan B, Hartge P, Hirsh-Yechezkel G et al (2001) Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med 345:235–240",
      "volume": "345",
      "year": "2001"
    },
    {
      "DOI": "10.1016/j.ejca.2004.09.008",
      "author": "T Rafnar",
      "doi-asserted-by": "crossref",
      "first-page": "2788",
      "journal-title": "Eur J Cancer",
      "key": "9112_CR15",
      "unstructured": "Rafnar T, Benediktsdottir KR, Eldon BJ et al (2004) BRCA2, but not BRCA1, mutations account for familial ovarian cancer in Iceland: a population-based study. Eur J Cancer 40:2788–2793",
      "volume": "40",
      "year": "2004"
    },
    {
      "DOI": "10.1016/S0002-9378(98)70476-4",
      "author": "SC Rubin",
      "doi-asserted-by": "crossref",
      "first-page": "670",
      "journal-title": "Am J Obstet Gynecol",
      "key": "9112_CR16",
      "unstructured": "Rubin SC, Blackwood MA, Bandera C et al (1998) BRCA1, BRCA2 and hereditary nonpolyposis colorectal cancer gene mutations in an unselected ovarian cancer population: relationship to family history and implications for genetic testing. Am J Obstet Gynecol 178:670–677",
      "volume": "178",
      "year": "1998"
    },
    {
      "author": "M Sekine",
      "first-page": "3144",
      "journal-title": "Clin Cancer Res",
      "key": "9112_CR17",
      "unstructured": "Sekine M, Nagata H, Tsuji S et al (2001) Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 7:3144–3150",
      "volume": "7",
      "year": "2001"
    },
    {
      "DOI": "10.1056/NEJM199704173361602",
      "author": "JF Stratton",
      "doi-asserted-by": "crossref",
      "first-page": "1125",
      "journal-title": "N Engl J Med",
      "key": "9112_CR18",
      "unstructured": "Stratton JF, Gayther SA, Russell P et al (1997) Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336:1125–1130",
      "volume": "336",
      "year": "1997"
    },
    {
      "author": "H Takahashi",
      "first-page": "2998",
      "journal-title": "Cancer Res",
      "key": "9112_CR19",
      "unstructured": "Takahashi H, Behbakht K, McGovern PE et al (1995) Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 55:2998–3002",
      "volume": "55",
      "year": "1995"
    },
    {
      "DOI": "10.1002/(SICI)1097-0215(20000601)86:5\u003c737::AID-IJC21\u003e3.0.CO;2-1",
      "author": "M Looij Van Der",
      "doi-asserted-by": "crossref",
      "first-page": "737",
      "journal-title": "Int J Cancer",
      "key": "9112_CR20",
      "unstructured": "Van Der Looij M, Szabo C, Besznyak I et al (2000) Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary. Int J Cancer 86:737–740",
      "volume": "86",
      "year": "2000"
    },
    {
      "DOI": "10.1016/S0959-8049(00)00110-6",
      "author": "H Anton-Culver",
      "doi-asserted-by": "crossref",
      "first-page": "1200",
      "journal-title": "Eur J Cancer",
      "key": "9112_CR21",
      "unstructured": "Anton-Culver H, Cohen PF, Gildea ME et al (2000) Characteristics of BRCA1 mutations in a population-based case series of breast and ovarian cancer. Eur J Cancer 36:1200–1208",
      "volume": "36",
      "year": "2000"
    },
    {
      "DOI": "10.1016/j.ejca.2004.10.011",
      "author": "EJ Majdak",
      "doi-asserted-by": "crossref",
      "first-page": "143",
      "journal-title": "Eur J Cancer",
      "key": "9112_CR22",
      "unstructured": "Majdak EJ, De Bock GH, Brozek I et al (2005) Prevalence and clinical correlations of BRCA1/BRCA2 unclassified variant carriers among unselected primary ovarian cancer cases—preliminary report. Eur J Cancer 41:143–150",
      "volume": "41",
      "year": "2005"
    },
    {
      "key": "9112_CR23",
      "unstructured": "American Cancer Society Inc (2005) Cancer facts \u0026 figures 2005. American Cancer Society Inc, Atlanta"
    },
    {
      "DOI": "10.1093/jnci/93.19.1458",
      "author": "SC Mok",
      "doi-asserted-by": "crossref",
      "first-page": "1458",
      "journal-title": "J Natl Cancer Inst",
      "key": "9112_CR24",
      "unstructured": "Mok SC, Chao J, Skates S et al (2001) Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst 93:1458–1464",
      "volume": "93",
      "year": "2001"
    },
    {
      "author": "JC Schink",
      "first-page": "59",
      "journal-title": "Semin Oncol",
      "key": "9112_CR25",
      "unstructured": "Schink JC (1999) Managing the care of patients with advanced ovarian cancer. Semin Oncol 26:59–61",
      "volume": "26",
      "year": "1999"
    },
    {
      "DOI": "10.3109/07853899509002463",
      "author": "PE Schwartz",
      "doi-asserted-by": "crossref",
      "first-page": "519",
      "journal-title": "Ann Med",
      "key": "9112_CR26",
      "unstructured": "Schwartz PE, Taylor KJ (1995) Is early detection of ovarian cancer possible? Ann Med 27:519–528",
      "volume": "27",
      "year": "1995"
    },
    {
      "DOI": "10.1148/radiology.192.1.8208918",
      "author": "KJ Taylor",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Radiology",
      "key": "9112_CR27",
      "unstructured": "Taylor KJ, Schwartz PE (1994) Screening for early ovarian cancer. Radiology 192:1–10",
      "volume": "192",
      "year": "1994"
    },
    {
      "DOI": "10.3322/canjclin.51.1.15",
      "author": "RT Greenlee",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "journal-title": "CA Cancer J Clin",
      "key": "9112_CR28",
      "unstructured": "Greenlee RT, Hill-Harmon MB, Murray T et al (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36",
      "volume": "51",
      "year": "2001"
    },
    {
      "DOI": "10.1002/cncr.11310",
      "author": "I Cass",
      "doi-asserted-by": "crossref",
      "first-page": "2187",
      "journal-title": "Cancer",
      "key": "9112_CR29",
      "unstructured": "Cass I, Baldwin RL, Varkey T et al (2003) Improved survival in women with BRCA-associated ovarian carcinoma. Cancer 97:2187–2195",
      "volume": "97",
      "year": "2003"
    },
    {
      "DOI": "10.1126/science.286.5442.1162",
      "author": "D Cortez",
      "doi-asserted-by": "crossref",
      "first-page": "1162",
      "journal-title": "Science",
      "key": "9112_CR30",
      "unstructured": "Cortez D, Wang Y, Qin J et al (1999) Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science 286:1162–1166",
      "volume": "286",
      "year": "1999"
    },
    {
      "author": "A Husain",
      "first-page": "1120",
      "journal-title": "Cancer Res",
      "key": "9112_CR31",
      "unstructured": "Husain A, He G, Venkatraman ES et al (1998) BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II). Cancer Res 58:1120–1123",
      "volume": "58",
      "year": "1998"
    },
    {
      "DOI": "10.1126/science.297.5588.1837",
      "author": "H Yang",
      "doi-asserted-by": "crossref",
      "first-page": "1837",
      "journal-title": "Science",
      "key": "9112_CR32",
      "unstructured": "Yang H, Jeffrey PD, Miller J et al (2002) BRCA2 function in DNA binding and recombination from a BRCA2–DSS1–ssDNA structure. Science 297:1837–1848",
      "volume": "297",
      "year": "2002"
    },
    {
      "author": "H Aida",
      "first-page": "235",
      "journal-title": "Clin Cancer Res",
      "key": "9112_CR33",
      "unstructured": "Aida H, Takakuwa K, Nagata H et al (1998) Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1. Clin Cancer Res 4:235–240",
      "volume": "4",
      "year": "1998"
    },
    {
      "DOI": "10.1200/JCO.2002.20.2.463",
      "author": "Y Ben David",
      "doi-asserted-by": "crossref",
      "first-page": "463",
      "journal-title": "J Clin Oncol",
      "key": "9112_CR34",
      "unstructured": "Ben David Y, Chetrit A, Hirsh-Yechezkel G et al (2002) Effect of BRCA mutations on the length of survival in epithelial ovarian tumors. J Clin Oncol 20:463–466",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1001/jama.283.17.2260",
      "author": "J Boyd",
      "doi-asserted-by": "crossref",
      "first-page": "2260",
      "journal-title": "JAMA",
      "key": "9112_CR35",
      "unstructured": "Boyd J, Sonoda Y, Federici MG et al (2000) Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA 283:2260–2265",
      "volume": "283",
      "year": "2000"
    },
    {
      "DOI": "10.1006/gyno.1993.1265",
      "author": "RE Buller",
      "doi-asserted-by": "crossref",
      "first-page": "160",
      "journal-title": "Gynecol Oncol",
      "key": "9112_CR36",
      "unstructured": "Buller RE, Anderson B, Connor JP et al (1993) Familial ovarian cancer. Gynecol Oncol 51:160–166",
      "volume": "51",
      "year": "1993"
    },
    {
      "DOI": "10.1056/NEJM199611073351901",
      "author": "SC Rubin",
      "doi-asserted-by": "crossref",
      "first-page": "1413",
      "journal-title": "N Engl J Med",
      "key": "9112_CR37",
      "unstructured": "Rubin SC, Benjamin I, Behbakht K et al (1996) Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 335:1413–1416",
      "volume": "335",
      "year": "1996"
    },
    {
      "DOI": "10.1200/JCO.1998.16.2.397",
      "author": "OT Johannsson",
      "doi-asserted-by": "crossref",
      "first-page": "397",
      "journal-title": "J Clin Oncol",
      "key": "9112_CR38",
      "unstructured": "Johannsson OT, Ranstam J, Borg A et al (1998) Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol 16:397–404",
      "volume": "16",
      "year": "1998"
    },
    {
      "author": "PD Pharoah",
      "first-page": "868",
      "journal-title": "Cancer Res",
      "key": "9112_CR39",
      "unstructured": "Pharoah PD, Easton DF, Stockton DL et al (1999) Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. Cancer Res 59:868–871",
      "volume": "59",
      "year": "1999"
    },
    {
      "author": "RF Ozols",
      "first-page": "958",
      "key": "9112_CR40",
      "unstructured": "Ozols RF, Rubin SC, Thomas G et al (1997) Epithelial ovarian cancer. In Hoskins WJ, Perez CA, Young RC (eds) Principles and principles of gynecologic oncology. Lippincott-Raven Publishers, Philadelphia, p 958",
      "volume-title": "Principles and principles of gynecologic oncology",
      "year": "1997"
    },
    {
      "author": "World Health Organization",
      "key": "9112_CR41",
      "unstructured": "World Health Organization (1979) WHO handbook for reporting results of cancer treatment. WHO, Geneva, Switzerland",
      "volume-title": "WHO handbook for reporting results of cancer treatment",
      "year": "1979"
    },
    {
      "DOI": "10.1200/JCO.2002.20.6.1480",
      "author": "TS Frank",
      "doi-asserted-by": "crossref",
      "first-page": "1480",
      "journal-title": "J Clin Oncol",
      "key": "9112_CR42",
      "unstructured": "Frank TS, Deffenbaugh AM, Reid JE et al (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480–1490",
      "volume": "20",
      "year": "2002"
    },
    {
      "DOI": "10.1038/ng1197-341",
      "author": "A Petrij-Bosch",
      "doi-asserted-by": "crossref",
      "first-page": "341",
      "journal-title": "Nat Genet",
      "key": "9112_CR43",
      "unstructured": "Petrij-Bosch A, Peelen T, van Vliet M et al (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 17:341–345",
      "volume": "17",
      "year": "1997"
    },
    {
      "DOI": "10.1086/302974",
      "doi-asserted-by": "crossref",
      "key": "9112_CR44",
      "unstructured": "The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group. Am J Hum Genet 67:207–212, 2000"
    },
    {
      "DOI": "10.1086/303076",
      "author": "MA Unger",
      "doi-asserted-by": "crossref",
      "first-page": "841",
      "journal-title": "Am J Hum Genet",
      "key": "9112_CR45",
      "unstructured": "Unger MA, Nathanson KL, Calzone K et al (2000) Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing. Am J Hum Genet 67:841–850",
      "volume": "67",
      "year": "2000"
    },
    {
      "DOI": "10.1002/1098-2264(200007)28:3\u003c300::AID-GCC8\u003e3.0.CO;2-1",
      "author": "EM Rohlfs",
      "doi-asserted-by": "crossref",
      "first-page": "300",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "9112_CR46",
      "unstructured": "Rohlfs EM, Puget N, Graham ML et al (2000) An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10. Genes Chromosomes Cancer 28:300–307",
      "volume": "28",
      "year": "2000"
    },
    {
      "author": "BC Ward",
      "first-page": "249",
      "journal-title": "Am J Hum Genet",
      "key": "9112_CR47",
      "unstructured": "Ward BC, Hendrikson CA, Gaglio T et al (2002) Identification of a novel 26 kb deletion in BRCA1 haplotype pair analysis [abstract]. Am J Hum Genet 71:249",
      "volume": "71",
      "year": "2002"
    },
    {
      "DOI": "10.1056/NEJM199611073351901",
      "author": "SC Rubin",
      "doi-asserted-by": "crossref",
      "first-page": "1413",
      "journal-title": "N Engl J Med",
      "key": "9112_CR48",
      "unstructured": "Rubin SC, Benjamin SC, Behbakht K et al (1997) Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA-1. N Engl J Med 335:1413–1416",
      "volume": "335",
      "year": "1997"
    }
  ],
  "reference-count": 48,
  "references-count": 48,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-006-9112-x"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Improved survival in BRCA2 carriers with ovarian cancer"
  ],
  "type": "journal-article",
  "volume": "6"
}